Matthew Pauls
Chief Executive Officer at SAVARA INC.
Net worth: 6 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anish Bhatnagar | M | 56 | 18 years | |
| David Ramsay | M | 59 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 13 years |
| Anne Erickson | F | - | 6 years | |
| Ernest Mario | M | 85 | 17 years | |
| Peter M. Clarke | M | 64 | 3 years | |
| David Lowrance | M | 56 | 7 years | |
| Robert M. Lutz | M | 55 | 9 years | |
| Birgitte Volck | M | 61 | 5 years | |
| Clare McGrory | F | - |
The Boys & Girls Clubs of Philadelphia
| - |
| Andrew Sinclair | M | 52 | 6 years | |
| Drayton Wise | M | 49 | 10 years | |
| Scott Wilhoit | M | 61 | 1 years | |
| Ricky Sun | M | 50 | 5 years | |
| Joseph McCracken | M | 71 | 7 years | |
| An van Es-Johansson | M | 64 | 5 years | |
| David McGirr | M | 69 | 11 years | |
| Richard Hawkins | M | 75 | 14 years | |
| Nevan Elam | M | 56 | 15 years | |
| Gwen Melincoff | M | 72 | 5 years | |
| Bill Harris | M | 65 | 10 years | |
| David Brennan | M | 70 | 10 years | |
| Michael Smith | M | 47 | 10 years | |
| Kate McCabe | F | - | 6 years | |
| Patricio Sepulveda | M | - |
Amplo Biotechnology, Inc.
 Amplo Biotechnology, Inc. BiotechnologyHealth Technology Amplo Biotechnology, Inc. operates as an American biotechnology company. The CEO of the company is Patricio Sepulveda. | - |
| Patricia Hirano | F | 58 | 7 years | |
| Scott Applebaum | M | 57 |
The Boys & Girls Clubs of Philadelphia
| - |
| Charles Horn | M | - | 2 years | |
| Kristen Yen | F | 55 | 18 years | |
| Joe Jordan | M | - |
The Boys & Girls Clubs of Philadelphia
| 11 years |
| Meredith S. Manning | F | - | - | |
| Jason Thacker | M | - |
The Boys & Girls Clubs of Philadelphia
| 11 years |
| Chris Papariello | M | - |
The Boys & Girls Clubs of Philadelphia
| 11 years |
| Lauren Budesheim | F | - | - | |
| Brian Markison | M | 64 |
The Pennington School
| - |
| Brian D. Crowe | M | 64 |
The Boys & Girls Clubs of Philadelphia
| - |
| William McComb | M | 61 |
The Pennington School
| - |
| Monica C. Holmes | M | 74 |
Central Michigan University
| 29 years |
| Thomas Hofmann | M | 72 |
The Boys & Girls Clubs of Philadelphia
| - |
| Michael Cola | M | 64 |
The Boys & Girls Clubs of Philadelphia
| - |
| James Mackaness | M | 60 | 5 years | |
| Michael D. Jingoli | M | - |
The Pennington School
| - |
| John E. Celentano | M | 64 |
The Pennington School
| - |
| Stephen Tan | M | 70 |
The Pennington School
| - |
| Raymond Pratt | M | 73 | 2 years | |
| Mike Diem | M | 54 |
The Boys & Girls Clubs of Philadelphia
| - |
| Jean J. Kim | F | 50 |
Amplo Biotechnology, Inc.
Amplo Biotechnology, Inc. BiotechnologyHealth Technology Amplo Biotechnology, Inc. operates as an American biotechnology company. The CEO of the company is Patricio Sepulveda. | - |
| Neil M. Cowen | M | - | 7 years | |
| Jamie Ohl | F | 58 |
The Boys & Girls Clubs of Philadelphia
| - |
| Tim Harmon | M | - |
The Pennington School
| - |
| James Hyman | M | - |
The Pennington School
| - |
| Charles LaPree | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Kollender | M | 54 | 2 years | |
| John Johnson | M | 66 | 6 years | |
| Brandi Roberts | F | 50 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 6 years |
| Peter Greenleaf | M | 54 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
| Howard C. Dittrich | M | 71 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 3 years |
| Garheng Kong | M | 49 | 6 years | |
| David Gill | M | 69 | 2 years | |
| Peter J. Valentinsson | M | - | - | |
| Cecilia Ganslandt | M | - | 5 years | |
| Thomas Luby | M | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 3 years |
| Robert Harrell | M | - |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Howard Mayer | M | 62 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 6 years |
| Marten Steen | M | 49 | - | |
| Ruth Thieroff-Ekerdt | M | 66 | - | |
| A. Davis | M | 57 | 4 years | |
| Taneli Jouhikainen | M | 57 | 3 years | |
| Andrea Holtzman Drucker | F | 66 | 2 years | |
| Shana C. Hood | F | - | - | |
| Jeffrey Sherman | M | 69 | 5 years | |
| Stephen J. Long | M | 58 | - | |
| Yuri Pikover | M | 62 | 6 years | |
| Brian Culley | M | 53 | - | |
| William Burns | M | 76 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Christine Pellizzari | F | 56 | 8 years | |
| Lewis J. Shuster | M | 68 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 5 years |
| Robert Norman Neville | M | 58 | 3 years | |
| Nancy A. Stempky | F | - |
Central Michigan University
| 1 years |
| Vandana Nadig Nair | M | - |
Central Michigan University
| 3 years |
| Bee Ling Yap | F | 45 |
Central Michigan University
| 4 years |
| Kevin Butler | M | - | - | |
| Paul Forte | M | - |
Central Michigan University
| 3 years |
| Derren Burrell | M | - |
Central Michigan University
| 2 years |
| Salvatore Orsini | M | 53 |
Central Michigan University
| 4 years |
| G. Robert Cook | M | - |
Central Michigan University
| 4 years |
| John P. Lavinus | M | - |
Central Michigan University
| 1 years |
| Joseph P. Brady | M | - |
Central Michigan University
| 1 years |
| Mark Decker | M | 56 |
Central Michigan University
| 4 years |
| T. J. Bucholz | M | - |
Central Michigan University
| 4 years |
| Wendy McGinnis | F | - |
Central Michigan University
| 3 years |
| DonDrea M. Esnault | M | - |
Central Michigan University
| 4 years |
| Gregg S. Rutgers | M | - |
Central Michigan University
| 4 years |
| Fred Diaz | M | 58 |
Central Michigan University
| 1 years |
| Jean Botti | M | 67 |
Central Michigan University
| 2 years |
| Mike Vandenbossche | M | - |
Central Michigan University
| 4 years |
| Richard Campbell | M | - |
Central Michigan University
| 4 years |
| William Graham | M | 63 |
Central Michigan University
| 2 years |
| Thomas M. Ihrig | M | - |
Central Michigan University
| 2 years |
| David Joseph Lajack | M | 70 |
Central Michigan University
| 4 years |
| Antonella Favit-van Pelt | M | 57 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Matthew Pauls
- Personal Network